期刊文献+

他克莫司和匹美克莫司的局部应用 被引量:2

下载PDF
导出
摘要 局部应用的他克莫司软膏和匹美克莫司霜是两种新的钙调磷酸酶抑制剂。作为局部免疫调节剂用于特应性皮炎的治疗。作为抗炎药其非常安全和较好疗效的特点 ,使它们成为治疗许多皮肤病的有吸引力的候选药物。已发表的文献表明它们除应用于特应性皮炎外 ,尚可用于银屑病、脂溢性皮炎。
出处 《国外医学(皮肤性病学分册)》 2003年第3期144-146,共3页 Foreign Medical Sciences(Section of Dermatology and Venereology)
  • 相关文献

参考文献13

  • 1Bekersky I, Lilja H, Lawrence I. Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic. Semin Cutan Med Surg,2001.20(4) :226 -232.
  • 2Stuetz A, Grassberger M, Meingassner JG. Pimecrolimus ( Elidel,SDZ ASM 981 ) - - preclinical pharmacologic profile and skin selectivity. Semin Cutan Med Surg, 2001, 20(4) :233 -241.
  • 3Boguniewicz M, Leung DY. Pathophysiologic mechanisms in atopic dermatitis. Semin Cutan Med Surg, 2001, 20(4) :217 -225.
  • 4Bergman J, Rico MJ. Tacrolimus clinical studies for atopic dermatitis and other conditions. Semin Cutan Med Surg, 2001, 20(4):250- 259.
  • 5Boguniewicz M, Fiedler VC, Raimer S,et al. A randomized, vehiclecontrolled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin lmmunol, 1998, 102(4 Pt 1) :637 -644.
  • 6Eichenfield LF, Lucky AW, Boguniewicz M,et al. Safety and efficacy of pimecrolimus (ASM 981 ) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol, 2002, 46 (4) :495 - 504.
  • 7Reitamo S, Van Leent E J, Ho V, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin lmmunol, 2002, 109(3) :539 -546.
  • 8Ling MR. Topical tacrolimus and pimecrolimus : future directions. Semin Cutan Med Surg, 2001, 20(4) :268 -274.
  • 9Mrowietz U, Graeber M, Brautigam M, et al. The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion. Br J Dermatol, 1998, 139(6) :992 -996.
  • 10Zonneveld IM, Rubins A, Jablonska S, et al. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol, 1998, 134(9) :1101 - 1102.

同被引文献12

  • 1孙红英,胡宝洋,周国民,俞立英.口腔扁平苔藓病理改变的免疫发病机制研究进展[J].复旦学报(医学版),2005,32(2):247-248. 被引量:6
  • 2庞劲凡.口腔扁平苔藓的药物治疗[J].中华老年口腔医学杂志,2006,4(1):45-47. 被引量:10
  • 3尚书,唐国瑶.口腔扁平苔藓疗效评价体系的标准化问题[J].临床口腔医学杂志,2006,22(9):570-571. 被引量:7
  • 4Setterfield JF, Black MM, Challacombe SJ. The management of oral lichen planus[J]. Clin Exp Dermatol, 2000,2:5 : 176-182.
  • 5Carbone M, Goss E, Carrozzo M, et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up [J].J Oral Pathol Med, 2003,32: 323-329.
  • 6Vente C, Reich K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: response to topical treatment with tacrolimus[J]. Br J Dermatol, 1999,140:338-342.
  • 7Ruzicka T, Assmann T, Homey B. Tacrolimus: The drug for the turn of the millennium[J].Arch Dermatol, 1999, 135 (5): 574.
  • 8Panhans-Gross A, Novak N, Kraft S, et al. Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus(FK506) [J]. J Allergy Clin Immunol, 2001, 107:345.
  • 9Kaliakatsou F, Hodgson TA, Lewsey JD, et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus[J]. J Am Acad Dermatol,2002,46:35--41.
  • 10郑际烈.口腔黏膜病诊断学[M].南京:江苏科学技术出版社,1999.9-9.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部